Track insider transactions across markets
Currently holds positions in Travere Therapeutics Inc, Genasys Inc and Standard BioTools Inc
| 30 days | 90 days | 120 days | |
|---|---|---|---|
| Average return | 7% | 8.2% | 15.1% |
| Success rate | 100% | 68% | 82% |
| Transactions |
4
0% Buy
|
34
71% Buy
|
47
69% Buy
|
| Position | Company | Period |
|---|---|---|
| Chief Financial Officer, Senior Vice President | Travere Therapeutics Inc | Nov. 17, 2014 - |
| Independent Director | Genasys Inc | Feb. 1, 2007 - |
| Independent Director | Standard BioTools Inc | Oct. 30, 2018 - |
Search